As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...

This episode of the Vet Blast Podcast presented by dvm360® educates listeners about the progression of myxomatous mitral valve disease using Vinnie, the 7-year-old Chihuahua, as a case study. In this ...

Inside the quiet revolution redefining how we experience solitude, focus, and identity on the road In the midst of ...

This is the 19th consecutive time that the performance-based learning and skill validation company has been named as a ...

Objective: The aim was to study the epidemiological aspects of febrile seizures and to identify etiologies in children from 1 ...